Igal Louria-Hayon
Director Técnico/Científico/I+D en RAPHAEL PHARMACEUTICAL INC. .
Fortuna: 658 341 $ al 30/04/2024
Perfil
Igal Louria-Hayon is currently the Scientific Director-Medical Cannabis Research at Rambam Health Care Campus and the Director & Chief Technology Officer at Raphael Pharmaceutical, Inc. He previously worked as the Chief Technology Officer & Chief Scientist at Easy Energy, Inc. and as the Head-Leukemia & Immunotherapy Research Laboratory at Clinical Research Institute (Israel).
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
29/08/2023 | 999 000 ( 5.35% ) | 658 341 $ | 30/04/2024 |
Cargos activos de Igal Louria-Hayon
Empresas | Cargo | Inicio |
---|---|---|
RAPHAEL PHARMACEUTICAL INC. | Director Técnico/Científico/I+D | 27/09/2021 |
Rambam Health Care Campus | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Igal Louria-Hayon.
Empresas | Cargo | Fin |
---|---|---|
Clinical Research Institute (Israel) | Corporate Officer/Principal | - |
Easy Energy, Inc.
Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel. | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
RAPHAEL PHARMACEUTICAL INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Easy Energy, Inc.
Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel. | Electronic Technology |
Rambam Health Care Campus | |
Clinical Research Institute (Israel) |
- Bolsa de valores
- Insiders
- Igal Louria-Hayon